Anticancer agent 25
Anticancer agent 25 is an anticancer agent. Anticancer agent 25 can arrest the cell cycle at the G1 phase, and significantly inhibit tumor cell colony forming and migration even at low concentrations. Anticancer agent 25 can significantly induce cytoplasmic vacuolation. Anticancer agent 25 can be used for the study of prostate cancer, breast cancer, and colon cancer[1].
Product Specifications
CAS Number
2401013-08-7
UNSPSC
12352005
Target
Drug Derivative; Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-25.html
Solubility
10 mM in DMSO
Smiles
CC(C)C(C=C1)=CC=C1CC2=C3C=CC(OC)=C(NCCCCCCCC)C3=C[N+]4=C2C5=CC6=C(C=C5CC4)OCO6.[Br-]
Molecular Formula
C37H45BrN2O3
Molecular Weight
645.67
References & Citations
[1]Wang ZC, et al. Synthesis and anticancer activity of novel 9,13-disubstituted berberine derivatives. Bioorg Med Chem Lett. 2020 Jan 15;30 (2) :126821.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
246405-AP 100 µL
FUT7 (Fucosyltransferase 7 (alpha (1,3) Fucosyltransferase), FucT-VII) (AP) discontinued
Sign In for Pricing
View Details ELI-15480h 96 Tests
Human Lysosome membrane protein 2, SCARB2 ELISA KIT
Sign In for Pricing
View Details 